The systemic lupus erythematosus tri-nation study: Cumulative indirect costs

Arthritis Care and Research

Volumn 57, Issue 1, 2007, Pages 64-70

  Panopalis, Pantelis ^a   Petri, Michelle ^b   Manzi, Susan ^c   Isenberg, David A ^d   Gordon, Caroline ^e   Senégal, Jean Luc ^f   Penrod, John R ^a   Joseph, Lawrence ^a   St Pierre, Yvan ^a   Pineau, Christian ^a   Fortin, Paul R ^g   Sutcliffe, Nurhan ^d   Goulet, Jean Richard ^f   Choquette, Denis ^f   Grodzicky, Tamara ^f   Esdaile, John M ^h   Clarke, Ann E ^a,i  

^a MCGILL UNIVERSITY   (Canada)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^f NOTRE DAME HOSPITAL   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

^h UNIVERSITY OF BRITISH COLUMBIA   (Canada)

ⁱ MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Indirect costs; Productivity; Systemic lupus erythematosis

Indexed keywords

ADULT; ARTICLE; CANADA; COST; DISEASE DURATION; ECONOMIC ASPECT; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HEALTH STATUS; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL DISABILITY; PRODUCTIVITY; QUESTIONNAIRE; SYSTEMIC LUPUS ERYTHEMATOSUS; UNITED KINGDOM; UNITED STATES; VISUAL ANALOG SCALE; WORK DISABILITY;

CANADA; COST OF ILLNESS; EFFICIENCY; GREAT BRITAIN; HEALTH CARE COSTS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; OUTCOME ASSESSMENT (HEALTH CARE); REGRESSION ANALYSIS; TIME FACTORS; UNITED STATES;

EID: 33846949359     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.22470     Document Type: Article

References (19)

1. Clarke AE, Esdaile JM, Bloch DA, Lacaille D, Danoff DS, Fries JF. A Canadian study of the total medical costs for patients with systemic lupus erythematosus and the predictors of costs. Arthritis Rheum 1993;36:1548-59.
2. Clarke AE, Penrod J, St Pierre Y, Petri MA, Manzi S, Isenberg DA, et al. Underestimating the value of women: assessing the indirect costs of women with systemic lupus erythematosus. J Rheumatol 2000;27:2597-604.
3. Allaire SH, Meenan RF, Anderson JJ. The impact of rheumatoid arthritis on the household work performance of women. Arthritis Rheum 1991;34:669-78.
4. Panopalis P, Petri M, Manzi S, Isenberg DA, Gordon C, Senecal JL, et al. The systemic lupus erythematosus tri-nation study: longitudinal changes in physical and mental well-being. Rheumatology (Oxford) 2005;44:751-5.
5. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
6. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
7. Clarke AE, Petri M, Manzi S, Isenberg DA, Gordon C, Senecal JL, et al, and the Tri-Nation Study Group. The systemic lupus erythematosus Tri-Nation Study: absence of a link between health resource use and health outcome. Rheumatology (Oxford) 2004;43:1016-24.
8. Fries JF, Spitz PW, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-44.
9. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
10. Kind P. The Euroqol instrument: an index of health-related quality of life. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. Philadelphia: Lippincott-Raven Publishers; 1996. p. 191-201.
11. Cohen AS, Mermelstein R, Kamarck T, Hoberman HM. Measuring the functional components of social support. In: Sarason IG, Sarason BR, editors. Social support: theory, research, and applications. The Hague: Martinus Nijhoff; 1985. p. 73-94.
12. Ware JE Jr, Snyder MK, Wright WR, Davies AR. Defining and measuring patient satisfaction with medical care. Eval Program Plann 1983;6:247-63.
13. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989;32:1107-18.
14. Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363-9.
15. Statistics Canada. General social survey 12, time use, 1998. Survey # 12M0012. Ottawa: Statistics Canada; 1998.
16. Partridge AJ, Karlson EW, Daltroy LH, Lew RA, Wright EA, Fossel AH, et al. Risk factors for early work disability in systemic lupus erythematosus: results from a multicenter study. Arthritis Rheum 1997;40:2199-206.
17. Zink A, Fischer-Betz R, Thiele K, Listing J, Huscher D, Gromnica-Ihle E, et al. Health care and burden of illness in systemic lupus erythematosus compared to rheumatoid arthritis: results from the National Database of the German Collaborative Arthritis Centres. Lupus 2004;13:529-36.
18. Mau W, Listing J, Huscher D, Zeidler H, Zink A. Employment across chronic inflammatory rheumatic diseases and comparison with the general population. J Rheumatol 2005;32:721-8.
19. Merkesdal S, Ruof J, Huelsemann JL, Mittendorf T, Handelmann S, Mau W, et al. Indirect cost assessment in patients with rheumatoid arthritis (RA): comparison of data from the Health Economic Patient Questionnaire HEQ-RA and insurance claims data. Arthritis Rheum 2005;53:234-40.